The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Measles is a disease caused by the virus Morbillivirus hominis. It’s an RNA virus in the family Paramyxoviridae—meaning it’s ...